These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30519359)

  • 1. Oxymatrine Synergistically Potentiates the Antitumor Effects of Cisplatin in Human Gastric Cancer Cells.
    Liu Y; Qin L; Bi T; Dai W; Liu W; Gao Q; Shen G
    J Cancer; 2018; 9(23):4527-4535. PubMed ID: 30519359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo.
    Liu Y; Bi T; Dai W; Wang G; Qian L; Gao Q; Shen G
    Tumour Biol; 2016 Jun; 37(6):7589-97. PubMed ID: 26687645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway.
    Liu Y; Bi T; Wang Z; Wu G; Qian L; Gao Q; Shen G
    Apoptosis; 2016 Dec; 21(12):1398-1407. PubMed ID: 27671687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation.
    Kong L; Wang X; Zhang K; Yuan W; Yang Q; Fan J; Wang P; Liu Q
    PLoS One; 2015; 10(9):e0137888. PubMed ID: 26368019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
    Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
    Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3β/cyclin D1 pathway.
    Wang J; Li XM; Bai Z; Chi BX; Wei Y; Chen X
    J Ethnopharmacol; 2018 Jan; 210():1-9. PubMed ID: 28684297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxymatrine Synergistically Enhances Doxorubicin Anticancer Effects in Colorectal Cancer.
    Pan D; Zhang W; Zhang N; Xu Y; Chen Y; Peng J; Chen Y; Zhang Y; Shen X
    Front Pharmacol; 2021; 12():673432. PubMed ID: 34305593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
    FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
    Wu QN; Liao YF; Lu YX; Wang Y; Lu JH; Zeng ZL; Huang QT; Sheng H; Yun JP; Xie D; Ju HQ; Xu RH
    Cancer Lett; 2018 Jan; 412():243-255. PubMed ID: 29050982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEA‑15 contributes to the clinicopathology and AKT‑regulated cisplatin resistance in gastric cancer.
    Jiang X; Zhang C; Li W; Jiang D; Wei Z; Lv M; Xie X; Sun X
    Oncol Rep; 2019 Mar; 41(3):1949-1959. PubMed ID: 30569123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxymatrine and Cisplatin Synergistically Enhance Anti-tumor Immunity of CD8
    Ye J; Zou MM; Li P; Lin XJ; Jiang QW; Yang Y; Huang JR; Yuan ML; Xing ZH; Wei MN; Li Y; Shi Z; Liu H
    Front Oncol; 2018; 8():631. PubMed ID: 30619765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated IL-24 expression enhances the chemosensitivity of multidrug-resistantgastric cancer cells to cisplatin.
    Mao Z; Bian G; Sheng W; He S; Yang J; Dong X
    Oncol Rep; 2013 Nov; 30(5):2288-96. PubMed ID: 23982423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Wogonoside reverses cisplatin resistance in SGC7901/cDDP cells through inhibition of PI3K/Akt/Nrf2/ARE signaling pathway].
    Wang LJ; Wang SG; Deng TX
    Sheng Li Xue Bao; 2018 Aug; 70(4):397-405. PubMed ID: 30112565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25-Dihydroxyvitamin D₃ and cisplatin synergistically induce apoptosis and cell cycle arrest in gastric cancer cells.
    Bao A; Li Y; Tong Y; Zheng H; Wu W; Wei C
    Int J Mol Med; 2014 May; 33(5):1177-84. PubMed ID: 24573222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 Polyunsaturated Fatty Acids Enhance Cisplatin Efficacy in Gastric Cancer Cells by Inducing Apoptosis via ADORA1.
    Sheng H; Chen X; Liu B; Li P; Cao W
    Anticancer Agents Med Chem; 2016; 16(9):1085-92. PubMed ID: 27025656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olean-28,13b-olide 2 plays a role in cisplatin-mediated apoptosis and reverses cisplatin resistance in human lung cancer through multiple signaling pathways.
    Zhu B; Ren C; Du K; Zhu H; Ai Y; Kang F; Luo Y; Liu W; Wang L; Xu Y; Jiang X; Zhang Y
    Biochem Pharmacol; 2019 Dec; 170():113642. PubMed ID: 31541631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vorinostat Potentiates 5-Fluorouracil/Cisplatin Combination by Inhibiting Chemotherapy-Induced EGFR Nuclear Translocation and Increasing Cisplatin Uptake.
    Piro G; Roca MS; Bruzzese F; Carbone C; Iannelli F; Leone A; Volpe MG; Budillon A; Di Gennaro E
    Mol Cancer Ther; 2019 Aug; 18(8):1405-1417. PubMed ID: 31189612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxymatrine exhibits anti-tumor activity in gastric cancer through inhibition of IL-21R-mediated JAK2/STAT3 pathway.
    Huang Y; Zhang J; Wang G; Chen X; Zhang R; Liu H; Zhu J
    Int J Immunopathol Pharmacol; 2018; 32():2058738418781634. PubMed ID: 30103640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax.
    Kim CW; Lu JN; Go SI; Jung JH; Yi SM; Jeong JH; Hah YS; Han MS; Park JW; Lee WS; Min YJ
    Int J Oncol; 2013 Nov; 43(5):1495-502. PubMed ID: 23970333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.